NPI registry status
Active
2026 NPPES data Medical Oncology Physician NPI 1063655108
Verify on CMS → Catherine Shu
Medical Oncology Physician in New York, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
134
Medicare Part D claims · 35 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
63%
generic claims · 37% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
100/100
▲ 17 pts above national avg 83.5 · Exceptional
Industry payments
$17.3K
17 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Catherine Shu reported a CMS MIPS final score of 100/100 - above the 83.5 national average - and filed 134 Medicare Part D claims in 2023.
- 100/100
- MIPS score · +17 vs avg
- 134
- Part D claims, 2023
- 63%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Catherine Shu's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
100 ≥ 92nd percentile 92% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Catherine Shu sits
This provider among medical oncology physician peers
Across the 1,398 medical oncology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Catherine Shu writes more Part D claims than 21% of them and scores higher on MIPS quality than 92% - placing this provider in the lower-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one medical oncology physician peer from a representative sample of 60; the gold marker is Catherine Shu. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Catherine Shu practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Catherine Shu?
High performer (top quartile)Primary specialty
Medical Oncology Physician
Medicare Part D claims
134 81% vs specialty avg
MIPS final score
100/100 16.5 pts vs avg
Specialty distribution in New York
How Medical Oncology Physician compares to other specialties among New York providers
Medicare quality performance, MIPS
Catherine Shu's 2023 MIPS final score plotted against the Medical Oncology Physician national average
- MIPS Final Score
- 100/100
- vs 83.5 national avg · 2023 performance year
MIPS final score (Medical Oncology Physician) - 100/100 vs national avg 83.5
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Catherine Shu appears in the CMS NPPES registry as a Medical Oncology Physician provider at 177 FORT WASHINGTON AVE, New York, NY, 10032, with a listed phone of (212) 305-6354. NPI 1063655108 was issued on 04/17/2009.
Medicare Part D records for calendar year 2023 show 134 prescription claims written by this provider, covering 35 Medicare beneficiaries and totaling roughly $568K in drug spend, split 37% brand-name and 63% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 100/100 for the 2023 performance year (Quality 86.8), compared with the 83.5 average among clinicians with a measured score.
Medical Oncology Physician is a narrow specialty nationwide, with 3,815 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1063655108 |
|---|---|
| Specialty | Medical Oncology Physician |
| Gender | Female |
| NPI Issued | 04/17/2009 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
100
Final Score
Measured-score avg: 83.5
86.8066
Quality
100
Promoting Interoperability
Reporting: Alternative Payment Model
Hospital and facility affiliations
Facilities where Catherine Shu bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Trustees OF Columbia University IN The City OF New York
New York, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Catherine Shu. Source: openpaymentsdata.cms.gov.
Total received
$17.3K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Catherine Shu. To verify Catherine Shu's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
Catherine Shu - brand share 37.0%
Medical Oncology Physician average
37% brand-name claims vs 63% generic, on 134 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
134
Total Claims
$568K
Total Drug Cost
35
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 158
- Total Day Supply
- 3,546
- Brand vs Generic
- 37% brand / 63% generic
- Brand Drug Cost
- $567K
- Generic Drug Cost
- $1K
Patient Demographics
- Average Patient Age
- 74.1 years
- Avg HCC Risk Score
- 2.50
- Gender Split
- 63% female / 37% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Catherine Shu prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ondansetron Hcl
Ondansetron Hcl
27 claims
- Prochlorperazine M…
Prochlorperazine Maleate
23 claims
- Tagrisso
Tagrisso
20 claims
| Drug | Claims |
|---|---|
| Ondansetron Hcl | 27 |
| Prochlorperazine Maleate | 23 |
| Tagrisso Osimertinib Mesylate | 20 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How Catherine Shu fits within the Medical Oncology Physician landscape nationally.
3,815
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider
Catherine Shu's 134 claims are below the specialty average of 689.
Nearby Medical Oncology Physician Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Shu.
Dr. Ghassan Abou-Alfa
MD
New York, NY
Nour Abuhadra
New York, NY
Melissa Accordino
New York, NY
Dr. David Aggen
M.D., PH.D.
New York, NY
Dr. Carol Aghajanian
MD
New York, NY
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Catherine Shu's specialty? ▼
Catherine Shu specializes in Medical Oncology Physician and practices in New York, New York.
How much does Catherine Shu prescribe under Medicare Part D? ▼
In 2023, Catherine Shu wrote 134 Medicare Part D claims totaling $568K in drug costs for 35 beneficiaries.
What is Catherine Shu's Medicare quality score? ▼
Catherine Shu has a CMS MIPS Final Score of 100/100 (Quality: 86.8). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Catherine Shu located? ▼
Catherine Shu is located at 177 FORT WASHINGTON AVE, New York, NY, 10032. Phone: (212) 305-6354.
What is Catherine Shu's NPI number? ▼
Catherine Shu's National Provider Identifier (NPI) is 1063655108, issued on 04/17/2009.
Does Catherine Shu prescribe more brand-name or generic drugs? ▼
Catherine Shu's prescribing is 37% brand-name and 63% generic drugs by claim count, with $567K in brand drug costs.
How many Medical Oncology Physician providers are there in the US? ▼
There are 3,815 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Catherine Shu prescribe most often? ▼
Based on 2023 Medicare Part D data, Catherine Shu's most frequently prescribed drugs include Ondansetron Hcl, Prochlorperazine Maleate, Tagrisso. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Catherine Shu accept Medicare? ▼
Catherine Shu appears in CMS Medicare data with 134 Part D claims and 35 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Catherine Shu's credentials? ▼
Catherine Shu's NPI is 1063655108. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.